accountDev., CFO of Allergan Inc. (AGN) Jeffrey L Edwards sells 32,592 shares of AGN on 11/06/2009 at an average price of $59.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ALLERGAN INC.
Allergan, Inc. is a global, multi-specialty healthcare company that operates in two business segments: specialty pharmaceuticals and medical devices. Their products include ophthalmic pharmaceuticals, dermatology products, and neurological products. Allergan, Inc.’s most notable product is Botox, which is used for therapeutic and aesthetic indications. The company was founded in 1948 and is headquartered in Irvine, California.
Allergan Inc. is part of Business Exchange, suggested by
Ulli Muenker.
This topic contains
211 news
and
83 blog
items.
Read updated news, blogs, and resources about Allergan Inc.. Find user-submitted articles and reactions on Allergan Inc. from
like-minded professionals.
Blogs
Recent blog posts on this topic.
This strength of ketorolac is therapeutically equivalent to Acular® Ophthalmic Solution, 0.5%, from Allergan, Inc.
Allergan, Inc., the maker of the drug Botox, recently filed suit against the Food & Drug Administration, alleging...
...http://www.companiesandmarkets.com/Summ...
Pharmaceuticals Inc., Cephalon Inc., Johnson & Johnson, Onyx Pharmaceuticals Inc, Sells Mead Johnson, Gilead...
Allergan Inc. (NYSE: AGN) reported better-than-expected Q3 numbers, sending shares higher. Bare Escentuals Inc.
Allergan Inc. reported quarterly earnings of $0.70 per share. The consensus earnings estimate was $0.69 per share.
BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended September 30, 2009.
Allergan, Inc. has announced that the United States District Court for the District of Delaware ruled in favor of...
...ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci, Inc., Exela PharmSci Pvt.
56.73 (-0.76) Volume 1,753,900 ... 10.29.09 LISTEN TO THE ALLERGAN, INC. THIRD QUARTER 2009 EARNINGS REPORT WEBCAST
Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of...
Oct. 24 (Bloomberg) -- Allergan Inc., the maker of Botox for wrinkles, won continued product protection when a judge...
A federal court ruled Friday that two generic-drug makers violated patents held by Allergan Inc. for glaucoma...
Dr. Ivan Goldsmith has sued Allergan Inc., the makers of Botox. Goldsmith argues that sales reps for Allergan Inc.
Reportlinker Adds Allergan Inc.: PharmaVitae Profile http://www.reportlinker.com/p0155102/Re...
Reportlinker.com announces that a new market research report is available in its catalogue.
• Allergan Inc., makers of Botox, have filed a lawsuit against federal health officials, which alleges that the...
NEW YORK — Allergan Inc., the maker of the Botox wrinkle treatment, challenged the government's ban on off-label drug...
Allergan Inc., which makes the Botox wrinkle treatment, is challenging the government's ban on off-label drug marketing...
Allergan, Inc. (NYSE: AGN) today filed a declaratory relief action in the United States District Court ...
Pasadena, CA -- BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial...
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board...
CHICAGO-(Business Wire)-September 18, 2009 - Zacks Equity Research highlights ON Semiconductor...
Top Sources: Allergan Inc.
- DailyMed Drug Label Updates for the last seven days (since Feb 12, 2009 EST)
- RedOrbit News - Health
- Finance Roundtable
- BioSpace.com Featured News and Stories
- Bloomberg.com Industries - Health Care News
- DailyMed Drug Label Updates for the last seven days (since Aug 8, 2009 EST)
- GuruFocus Updates -
- 247 Wall Street
- BeautyNewsNYC
- Best Syndication - All News
